Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.85 - $1.41 $46,092 - $76,458
-54,226 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$1.16 - $2.5 $8,601 - $18,537
7,415 Added 15.84%
54,226 $71,000
Q4 2021

Feb 11, 2022

BUY
$2.46 - $8.74 $5,675 - $20,163
2,307 Added 5.18%
46,811 $115,000
Q3 2021

Nov 04, 2021

SELL
$5.1 - $9.39 $57,629 - $106,107
-11,300 Reduced 20.25%
44,504 $380,000
Q2 2021

Aug 11, 2021

BUY
$3.95 - $6.88 $65,080 - $113,354
16,476 Added 41.89%
55,804 $357,000
Q1 2021

May 13, 2021

BUY
$2.01 - $5.55 $27,577 - $76,146
13,720 Added 53.58%
39,328 $174,000
Q4 2020

Feb 16, 2021

BUY
$1.73 - $2.13 $12,732 - $15,676
7,360 Added 40.33%
25,608 $54,000
Q3 2020

Nov 12, 2020

BUY
$1.76 - $2.17 $3,058 - $3,771
1,738 Added 10.53%
18,248 $32,000
Q2 2020

Aug 13, 2020

BUY
$1.75 - $2.65 $28,892 - $43,751
16,510 New
16,510 $35,000
Q1 2018

May 15, 2018

SELL
$1.51 - $3.21 $7,399 - $15,729
-4,900 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$2.18 - $5.7 $2,616 - $6,840
1,200 Added 32.43%
4,900 $11,000
Q3 2017

Nov 14, 2017

BUY
$2.84 - $8.59 $10,508 - $31,783
3,700
3,700 $20,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $97.4M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.